Breaking News, Promotions & Moves

Karyopharm Welcomes New Chief Financial Officer

Lori Macomber has been appointed as Executive Vice President, Chief Financial Officer and Treasurer.

Author Image

By: Charlie Sternberg

Associate Editor

Lori Macomber.

Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company pioneering novel cancer therapies, has appointed Lori Macomber as Executive Vice President, Chief Financial Officer and Treasurer, effective January 3, 2025. In this role, Macomber will be responsible for leading and directing the financial activities of the Company. “Lori is an outstanding addition to the Karyopharm team,” said Richard Paulson, President and CEO of Karyopharm. “She brings extensive e...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters